{"id":63012,"date":"2026-04-27T22:02:22","date_gmt":"2026-04-27T20:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/"},"modified":"2026-04-27T22:02:22","modified_gmt":"2026-04-27T20:02:22","slug":"post-durnell-argument-scenario-statements-attributable-to-monsanto","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/","title":{"rendered":"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto"},"content":{"rendered":"<div>\n<p>LEVERKUSEN, Germany &amp; ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;\u201cWe appreciate the Court\u2019s careful consideration of FIFRA\u2019s Uniformity language and how its federal preemption provision applies to state-based label warnings.<\/p>\n<p>\n\u201cWe believe the U.S. Government and the Company made persuasive arguments that state-based warning claims \u2018in addition to or different from\u2019 warning labels approved by EPA under FIFRA, as in <i>Durnell,<\/i> are preempted, and this is necessary to avoid a patchwork of 50 different warning labels. Companies should not be punished under state law for complying with federal label requirements. The security and affordability of the nation\u2019s food supply depend on farmers\u2019 and manufacturers\u2019 ability to rely on the science-based judgments of federal regulators. A favorable ruling by the Supreme Court would provide essential regulatory clarity for companies who seek to bring currently approved and new products to market, addressing their ability to serve U.S. farmers and consumers.\u201d<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedia Contact:<br \/>\n<br \/>Brian Leake<br \/>\n<br \/>(314) 370.3285<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEVERKUSEN, Germany &amp; ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;\u201cWe appreciate the Court\u2019s careful consideration of FIFRA\u2019s Uniformity language and how its federal preemption provision applies to state-based label warnings. \u201cWe believe the U.S. Government and the Company made persuasive arguments that state-based warning claims \u2018in addition to or different from\u2019 warning labels approved by EPA under FIFRA, as &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-63012","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LEVERKUSEN, Germany &amp; ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;\u201cWe appreciate the Court\u2019s careful consideration of FIFRA\u2019s Uniformity language and how its federal preemption provision applies to state-based label warnings. \u201cWe believe the U.S. Government and the Company made persuasive arguments that state-based warning claims \u2018in addition to or different from\u2019 warning labels approved by EPA under FIFRA, as ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-27T20:02:22+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto\",\"datePublished\":\"2026-04-27T20:02:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/\"},\"wordCount\":164,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/\",\"name\":\"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2026-04-27T20:02:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/post-durnell-argument-scenario-statements-attributable-to-monsanto\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/","og_locale":"en_US","og_type":"article","og_title":"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto - Pharma Trend","og_description":"LEVERKUSEN, Germany &amp; ST. LOUIS&#8211;(BUSINESS WIRE)&#8211;\u201cWe appreciate the Court\u2019s careful consideration of FIFRA\u2019s Uniformity language and how its federal preemption provision applies to state-based label warnings. \u201cWe believe the U.S. Government and the Company made persuasive arguments that state-based warning claims \u2018in addition to or different from\u2019 warning labels approved by EPA under FIFRA, as ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/","og_site_name":"Pharma Trend","article_published_time":"2026-04-27T20:02:22+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto","datePublished":"2026-04-27T20:02:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/"},"wordCount":164,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/","url":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/","name":"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2026-04-27T20:02:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/post-durnell-argument-scenario-statements-attributable-to-monsanto\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Post Durnell Argument Scenario Statements \u2013 Attributable to Monsanto"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63012","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=63012"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/63012\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=63012"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=63012"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=63012"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}